Breaking News Instant updates and real-time market news.

MON

Monsanto

$101.61

-0.32 (-0.31%)

, BAYRY

Bayer

$100.13

-0.07 (-0.07%)

08:29
10/05/16
10/05
08:29
10/05/16
08:29

Monsanto sees FY17 Ag Productivity gross profit $900M-$1B

Commenting on the deal with Bayer (BAYRY), Monsanto (MON) notes that it is all-cash consideration of $128 per Monsanto share. The deal includes a reverse break-up fee of $2B, including divestiture commitments. The transaction has been unanimously approved by Monsanto's Board of Directors, Bayer's Board of Management and Bayer's Supervisory Board, Monsanto said. The company expects the transaction to close at the end of 2017. Sees FY17 Seeds & Genomics gross profit increase in the mid-single digits. Sees FY17 Ag Productivity gross profit $900M-$1B. Sees restructuring expense of about $1B-$1.1B from FY15-FY18, sees total expected savings of $500M in FY18. Comments from slides that will be presented on the Q4 earnings conference call.

MON

Monsanto

$101.61

-0.32 (-0.31%)

BAYRY

Bayer

$100.13

-0.07 (-0.07%)

  • 05

    Oct

MON Monsanto
$101.61

-0.32 (-0.31%)

09/21/16
09/21/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Monsanto (MON) upgraded to Overweight from Neutral at JPMorgan with analyst Jeffrey Zekauskas saying the risk in the shares is "less than what the market assumes." 2. Barclays (BCS) upgraded to Buy from Hold at HSBC citing the pending disposal of non-core businesses and resulting value creation. 3. Etsy (ETSY) upgraded to Buy from Neutral at Monness Crespi with the firm's analyst believing that Etsy shares can still move higher and sees a solid opportunity for upward revisions from improving conversion rates due to enhanced search and mobile functionality, expanding take rates, and advanced cross-boarder commerce capabilities with vendors. 4. Clovis (CLVS) upgraded to Outperform from Neutral at Credit Suisse with analyst Kennen MacKay saying the potential for a takeover "outweighs concerns surrounding patent life, limited experience in platinum resistant/refractory patients, and PARPi competition." 5. Jabil Circuit (JBL) upgraded to Buy from Neutral at UBS with analyst Steven Milunovich saying the company's cash flow is nearing an inflection amid an upturn in its Apple (AAPL) business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/16
BERN
09/26/16
UPGRADE
BERN
Market Perform
Monsanto upgraded to Market Perform from Underperform at Bernstein
09/26/16
BERN
09/26/16
UPGRADE
BERN
Market Perform
Monsanto upgraded on acquisition at Bernstein
As noted earlier, Bernstein upgraded Monsanto (MON) to Market Perform from Underperform. Analyst Jonas Oxgaard upgraded the stock after Bayer (BAYRY) agreed to buy Monsanto. However, he warned that "it's too early to tell" whether regulators will approve the deal, and he says that the risk is "skewed to the downside in the near-term." He recommends that investors avoid the stock for 6-9 months. Target to $105 from $90.
09/27/16
GSCO
09/27/16
UPGRADE
GSCO
Neutral
Monsanto upgraded to Neutral from Sell at Goldman
BAYRY Bayer
$100.13

-0.07 (-0.07%)

09/15/16
PIPR
09/15/16
NO CHANGE
Target $128
PIPR
Overweight
Piper has confidence in closing of Monsanto, Bayer merger
Piper Jaffray analyst Brett Wong raised his price target for Monsanto (MON) to $128 citing the takeover price paid by Bayer (BAYRY). The analyst views the offer price as lower than expected but has confidence regulatory approval will be granted since there is a minimal crossover between the two companies. He reiterates an Overweight rating on Monsanto.
09/15/16
BERN
09/15/16
NO CHANGE
BERN
Bayer acquisition negative, says Bernstein
After Bayer (BAYRY) agreed to buy Monsanto (MON), Bernstein analyst Jonas Oxgaard says he "continues to have a bearish view" of Monsanto's business, and he thinks that Monsanto's price exceeded the company's true value by about 60%. The analyst adds that the genetically modified products that Monsanto is developing "are not expected to command outsized premiums," while genetically modified seeds have nearly fully penetrated most of the Americas. He keeps an Underperform rating on Monsanto and an Outperform rating on Bayer.
09/21/16
JPMS
09/21/16
UPGRADE
Target $128
JPMS
Overweight
Monsanto upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas upgraded Monsanto (MON) to Overweight saying the risk in the shares is "less than what the market assumes." The analyst believes downside risk should the takeover by Bayer (BAYRY) fail is around $100 per share. He notes that Monsanto shareholders would receive $128 per share should the acquisition close. Zekauskas raised his price target for Monsanto to $128 from $100.

TODAY'S FREE FLY STORIES

GIS

General Mills

08:39
09/20/17
09/20
08:39
09/20/17
08:39
Hot Stocks
General Mills says expects margin headwinds to lessen during remainder of FY18 »

Says remains on track for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

GM

General Motors

$38.70

0.11 (0.29%)

08:39
09/20/17
09/20
08:39
09/20/17
08:39
Recommendations
General Motors analyst commentary  »

Citi makes case for GM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGI

Celadon Group

$6.50

-0.05 (-0.76%)

08:38
09/20/17
09/20
08:38
09/20/17
08:38
Hot Stocks
Celadon Group closing its truck driving academy »

Celadon Trucking will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALIOF

Actelion

08:35
09/20/17
09/20
08:35
09/20/17
08:35
Conference/Events
Actelion has a conference call hosted by JPMorgan »

JPMorgan Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

BBBY

Bed Bath & Beyond

$27.03

-0.27 (-0.99%)

08:33
09/20/17
09/20
08:33
09/20/17
08:33
Recommendations
Bed Bath & Beyond analyst commentary  »

Bed Bath trends getting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMP

Ameriprise

$141.23

0.37 (0.26%)

08:33
09/20/17
09/20
08:33
09/20/17
08:33
Hot Stocks
Columbia Threadneedle Investments to acquire Lionstone Investments »

Columbia Threadneedle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEET

Meet Group

$3.84

-0.09 (-2.29%)

08:33
09/20/17
09/20
08:33
09/20/17
08:33
Hot Stocks
Meet Group to acquire social dating app LOVOO for $70M in cash »

The Meet Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECL

Ecolab

$130.74

0.21 (0.16%)

08:31
09/20/17
09/20
08:31
09/20/17
08:31
Hot Stocks
Nalco Champion announces price increase for customers in all segments »

Nalco Champion, an Ecolab…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SR

Spire

$75.35

-0.05 (-0.07%)

, MC

Moelis

$41.35

0.6 (1.47%)

08:31
09/20/17
09/20
08:31
09/20/17
08:31
Conference/Events
American Gas Association to hold a forum »

2017 Mini-Forum for the…

SR

Spire

$75.35

-0.05 (-0.07%)

MC

Moelis

$41.35

0.6 (1.47%)

ATO

Atmos Energy

$85.93

-0.57 (-0.66%)

CPK

Chesapeake Utilities

$77.40

-1.65 (-2.09%)

ED

Consolidated Edison

$83.41

-0.16 (-0.19%)

ES

Eversource

$61.77

0.08 (0.13%)

NI

NiSource

$26.40

-0.14 (-0.53%)

NWN

Northwest Natural Gas

$65.85

-0.3 (-0.45%)

OGS

ONE Gas

$74.60

-0.11 (-0.15%)

SJI

South Jersey Industries

$35.14

-0.28 (-0.79%)

UGI

UGI Corporation

$47.74

-0.17 (-0.35%)

VVC

Vectren

$66.00

-0.35 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 25

    Sep

  • 22

    Oct

  • 31

    Oct

  • 05

    Nov

SCVL

Shoe Carnival

08:31
09/20/17
09/20
08:31
09/20/17
08:31
Upgrade
Shoe Carnival rating change  »

Shoe Carnival upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

KSS

Kohl's

$45.38

0.49 (1.09%)

, AMZN

Amazon.com

$969.86

-4.33 (-0.44%)

08:30
09/20/17
09/20
08:30
09/20/17
08:30
Recommendations
Kohl's, Amazon.com analyst commentary  »

Citi likes Kohl's…

KSS

Kohl's

$45.38

0.49 (1.09%)

AMZN

Amazon.com

$969.86

-4.33 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 09

    Nov

MORE

Monogram Residential Trust

08:30
09/20/17
09/20
08:30
09/20/17
08:30
Options
One option delisting on September 20th »

Option delistings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$53.54

-4.26 (-7.37%)

08:29
09/20/17
09/20
08:29
09/20/17
08:29
Recommendations
NuVasive analyst commentary  »

NuVasive price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEMP

Gemphire Therapeutics

$9.65

0.54 (5.93%)

08:29
09/20/17
09/20
08:29
09/20/17
08:29
Recommendations
Gemphire Therapeutics analyst commentary  »

Gemphire data support…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RDUS

Radius Health

$33.99

0.28 (0.83%)

08:26
09/20/17
09/20
08:26
09/20/17
08:26
Conference/Events
Radius Health has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

JAZZ

Jazz Pharmaceuticals

$151.18

-1.47 (-0.96%)

08:25
09/20/17
09/20
08:25
09/20/17
08:25
Recommendations
Jazz Pharmaceuticals analyst commentary  »

Doctor feedback on Jazz…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

, IONS

Ionis Pharmaceuticals

$59.07

-0.5 (-0.84%)

08:24
09/20/17
09/20
08:24
09/20/17
08:24
Recommendations
Alnylam, Ionis Pharmaceuticals analyst commentary  »

Alnylam study 'hits…

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

IONS

Ionis Pharmaceuticals

$59.07

-0.5 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

NWBO

Northwest Biotherapeutics

$0.22

0.004 (1.86%)

08:24
09/20/17
09/20
08:24
09/20/17
08:24
Syndicate
Northwest Biotherapeutics raises $1.75M in a registered direct offering »

Northwest Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:23
09/20/17
09/20
08:23
09/20/17
08:23
Conference/Events
Federal Reserve Chairperson Yellen holds a press conference »

Following a quarterly…

LB

L Brands

$39.23

-0.75 (-1.88%)

08:23
09/20/17
09/20
08:23
09/20/17
08:23
Downgrade
L Brands rating change  »

L Brands downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$3.93

-0.05 (-1.26%)

08:22
09/20/17
09/20
08:22
09/20/17
08:22
Hot Stocks
Lipocine announces FDA advisory committee meeting for Tlando »

Lipocine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

$DJT

DJ Transportation Average

08:22
09/20/17
09/20
08:22
09/20/17
08:22
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:21
09/20/17
09/20
08:21
09/20/17
08:21
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:21
09/20/17
09/20
08:21
09/20/17
08:21
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$171.61

-0.11 (-0.06%)

08:21
09/20/17
09/20
08:21
09/20/17
08:21
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.